Age-related macular degeneration (AMD) is the leading cause of severe vision loss among older adults in the Western world, affecting over 25 million people in the USA alone, primarily the elderly.
There are 2 kinds of age-related macular degeneration (AMD): dry and wet. Dry AMD is more common, representing approximately 90% of all AMD cases, and is generally not as damaging to vision as the wet form. Dry AMD can convert into wet AMD at any time.
AMD is also classified into different categories:
- Category 1: Few small (< 63 micrometers [µm]) or no drusen
- Category 2: Early AMD, having many small drusen or a few intermediate-sized (≥ 63 µm and <125 µm) drusen.
- Category 3: Extensive intermediate drusen or at least one large (≥125 µm) drusen.
- Category 4: Advanced AMD in 1 eye, either Geographic Atrophy (GA) in the center or neovascular AMD
Once the signs of AMD is noted , running a test to see your risk of progression is is done a via simple 3 step process.
1. At the office
A cheek sample is collected and the 1 page Test Requisition Form is filled in.
The sample package, with insurance information and filled-in TRF is put inside the prepaid envelope.
Our office receives the patient report within 2 weeks of sample receipt at the testing laboratory. The report includes the Macula Risk test result as well as patient genetic counseling support.
The Macula Risk Test is simple and non-invasive and is covered by Medicare and most insurance providers.
In fact we guarantee there will be no out of pocket cost for you to take this test if we do it at one of your regular appointments!